NCT06678724View on ClinicalTrials.gov

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Head and Neck Cancers- Squamous CellHead and Neck Cancer MetastaticRecurrent Head and Neck Squamous Cell Carcinoma
Trial Locations (1)

302058

National Taiwan University HsinChu Branch, Zhubei

All Listed Sponsors
collaborator

National Taiwan University Hospital Hsin-Chu Branch

OTHER

collaborator

National Taiwan University Hospital, Yun-Lin Branch

OTHER

lead

National Taiwan University Hospital

OTHER